Clinical trial

Exenatide in Extreme Pediatric Obesity

NCT01237197

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Exenatide Normalized identity: exenatideView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Exenatide in Extreme Pediatric Obesity

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2010-10-01

PhasePHASE2

Conditions

Obesityverified · MONDO: obesity disorder

Interventions

ExenatideDRUG · verified · RxNorm: exenatide

PlaceboDRUG

Sponsors & collaborators

University of Minnesotalead sponsor

Children's Hospitals and Clinics of Minnesotacollaborator

Mapped research locations

MinneapolisMinnesota, United States1 Saint PaulMinnesota, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01237197 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.